Validation of ovarian cancer gene expression signatures for survival and subtype in formalin fixed paraffin embedded tissues

Gynecologic Oncology

Volumn 129, Issue 1, 2013, Pages 159-164

  Sfakianos, Gregory P ^a   Iversen, Edwin S ^a   Whitaker, Regina ^a   Akushevich, Liudmila ^a   Schildkraut, Joellen M ^a   Murphy, Susan K ^a   Marks, Jeffrey R ^a   Berchuck, Andrew ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Gene expression; Histological subtype; Microarray; Ovarian cancer; Survival

Indexed keywords

RNA 18S;

ARTICLE; CANCER SURVIVAL; CANCER TISSUE; FEMALE; FORMALIN FIXED PARAFFIN EMBEDDED TISSUE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; MICROARRAY ANALYSIS; OVARY CARCINOMA; PRIORITY JOURNAL; RNA EXTRACTION; RNA ISOLATION; TUMOR GENE; VALIDATION PROCESS;

FEMALE; FORMALDEHYDE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; OVARIAN NEOPLASMS; PARAFFIN EMBEDDING;

EID: 84884212036     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2012.12.030     Document Type: Article

References (21)

1. J.A. Sparano, and S. Paik Development of the 21-gene assay and its application in clinical practice and clinical trials J Clin Oncol 26 2008 721 728
2. M.F. Press, G. Sauter, L. Bernstein, I.E. Villalobos, M. Mirlacher, and J.Y. Zhou Diagnostic evaluation of HER-2 as a molecular target: an assessment of accuracy and reproducibility of laboratory testing in large, prospective, randomized clinical trials Clin Cancer Res 11 2005 6598 6607
3. A. Berchuck, E.S. Iversen, J. Luo, J.P. Clarke, H. Horne, and D.A. Levine Microarray analysis of early stage serous ovarian cancers shows profiles predictive of favorable outcome Clin Cancer Res 15 2009 2448 2455
4. T. Bonome, J.Y. Lee, D.C. Park, M. Radonovich, C. Pise-Masison, and J. Brady Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary Cancer Res 65 2005 10602 10612
5. D. Spentzos, D.A. Levine, S. Kolia, H. Otu, J. Boyd, and T.A. Libermann Unique gene expression profile based on pathologic response in epithelial ovarian cancer J Clin Oncol 23 2005 7911 7918
6. V. Shridhar, J. Lee, A. Pandita, S. Iturria, R. Avula, and J. Staub Genetic analysis of early- versus late-stage ovarian tumors Cancer Res 61 2001 5895 5904
7. D. Spentzos, D.A. Levine, M.F. Ramoni, M. Joseph, X. Gu, and J. Boyd Gene expression signature with independent prognostic significance in epithelial ovarian cancer J Clin Oncol 22 2004 4648 4658
8. T. Bonome, D.A. Levine, J. Shih, M. Randonovich, C.A. Pise-Masison, and F. Bogomolniy A gene signature predicting for survival in suboptimally debulked patients with ovarian cancer Cancer Res 68 2008 5478 5486
9. R.W. Tothill, A.V. Tinker, J. George, R. Brown, S.B. Fox, and S. Lade Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome Clin Cancer Res 14 2008 5198 5208
10. Cancer Genome Atlas Research N Integrated genomic analyses of ovarian carcinoma Nature 474 2011 609 615
11. Y. Hoshida, A. Villanueva, M. Kobayashi, J. Peix, D.Y. Chiang, and A. Camargo Gene expression in fixed tissues and outcome in hepatocellular carcinoma N Engl J Med 359 2008 1995 2004
12. J.M. Schildkraut, E.S. Iversen, M.A. Wilson, M.A. Clyde, P.G. Moorman, and R.T. Palmieri Association between DNA damage response and repair genes and risk of invasive serous ovarian cancer PLoS One 5 2010 e10061
13. R.A. Irizarry, B. Hobbs, F. Collin, Y.D. Beazer-Barclay, K.J. Antonellis, and U. Scherf Exploration, normalization, and summaries of high density oligonucleotide array probe level data Biostatistics 4 2003 249 260
14. G.K. Smyth Limma: linear models for microarray data R. Gentleman, V. Carey, S. Dudoit, R. Irizarry, W. Huber, Bioinformatics and computational biology solutions using R and bioconductor 2005 Springer New York 397 420
15. W. Shi, A. Oshlack, and G.K. Smyth Optimizing the noise versus bias trade-off for Illumina whole genome expression BeadChips Nucleic Acids Res 38 2010 e204
16. Z.L. Xiang, Z.C. Zeng, J. Fan, Z.Y. Tang, H.Y. Zeng, and D.M. Gao Gene expression profiling of fixed tissues identified hypoxia-inducible factor-1alpha, VEGF, and matrix metalloproteinase-2 as biomarkers of lymph node metastasis in hepatocellular carcinoma Clin Cancer Res 17 2011 5463 5472
17. Y. Xie, G. Xiao, K.R. Coombes, C. Behrens, L.M. Solis, and G. Raso Robust gene expression signature from formalin-fixed paraffin-embedded samples predicts prognosis of non-small-cell lung cancer patients Clin Cancer Res 17 2011 5705 5714
18. R.D. Kennedy, M. Bylesjo, P. Kerr, T. Davison, J.M. Black, and E.W. Kay Development and independent validation of a prognostic assay for stage II colon cancer using formalin-fixed paraffin-embedded tissue J Clin Oncol 29 2011 4620 4626
19. J. Chien, J.B. Fan, D.A. Bell, C. April, B. Klotzle, and T. Ota Analysis of gene expression in stage I serous tumors identifies critical pathways altered in ovarian cancer Gynecol Oncol 114 2009 3 11
20. L. Mittempergher, J.J. de Ronde, M. Nieuwland, R.M. Kerkhoven, I. Simon, and E.J. Rutgers Gene expression profiles from formalin fixed paraffin embedded breast cancer tissue are largely comparable to fresh frozen matched tissue PLoS One 6 2011 e17163
21. A. Berchuck, E.S. Iversen, J.M. Lancaster, J. Pittman, J. Luo, and P. Lee Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers Clin Cancer Res 11 2005 3686 3696